Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma (Sitax)

This study has been terminated.
(sitaxentan is not commercialized anymore)
Information provided by (Responsible Party):
Institut National de la Santé Et de la Recherche Médicale, France Identifier:
First received: January 14, 2010
Last updated: May 9, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)